Novel treatments for osteoarthritis: a recent update
Yong Wu,1,* En Lin Goh,2,* Dong Wang,3 Shaocheng Ma3 1Leicester Medical School, University of Leicester, Leicester, UK; 2Faculty of Medicine, Imperial College London, London, UK; 3Biomechanics Research Group, Imperial College London, London, UK *These authors contributed equally to this work Abstrac...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/18631992bd6945f3b19855b4a20037ee |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Yong Wu,1,* En Lin Goh,2,* Dong Wang,3 Shaocheng Ma3 1Leicester Medical School, University of Leicester, Leicester, UK; 2Faculty of Medicine, Imperial College London, London, UK; 3Biomechanics Research Group, Imperial College London, London, UK *These authors contributed equally to this work Abstract: Osteoarthritis is the most prevalent chronic joint condition worldwide. The principles of osteoarthritis treatment are to alleviate pain and stiffness as well as maintain function, with current consensus guidelines recommending the use of a combination of conservative measures including physical therapy, analgesia, and surgical interventions such as arthroplasty. In recent years, several pharmacological therapies have emerged as potential alternatives. Although a disease-modifying osteoarthritis drug has yet to be identified, promising results have been reported in recent trials especially with serotonin–norepinephrine reuptake inhibitors, IL-1 antagonists, and antibodies to nerve growth factor. The present review aims to summarize and discuss the latest results of novel treatments for osteoarthritis and potential targets for future research. Keywords: osteoarthritis, novel treatment, future therapy, review |
|---|